Related Experiment Videos
[Surgery or radiotherapy for cervical carcinoma stage IIb]
Geburtshilfe Und Frauenheilkunde
|December 1, 1983
Summary
This study compared surgical versus irradiation treatments for stage IIb cervical cancer patients from 1964-1976. Surgery showed higher survival rates, but many cases were overestimated, suggesting caution with surgical interventions for this cancer stage.
Area of Science:
- Gynecologic Oncology
- Clinical Oncology
- Radiation Oncology
Background:
- Cervical cancer remains a significant global health concern.
- Stage IIb cervical cancer presents specific treatment challenges.
- Comparing treatment modalities is crucial for optimizing patient outcomes.
Purpose of the Study:
- To evaluate the five-year survival rates of stage IIb cervical cancer patients.
- To compare the efficacy of primary surgical treatment versus primary irradiation.
- To identify factors influencing survival in stage IIb cervical cancer.
Main Methods:
- Retrospective analysis of 134 stage IIb cervical cancer cases (1964-1976).
- Patients received either primary surgery or primary irradiation.
- Five-year survival rates were calculated and compared between treatment groups.
Main Results:
- The five-year survival rate was 57.69% for the surgical group (n=78) and 42.86% for the irradiation group (n=56).
- A significant proportion (65.38%) of surgically treated cases were found to be clinically overestimated (histological stages Ib, Ic, IIa).
- For patients accurately staged as IIb (n=27), the five-year survival rate after surgery was only 29.62%.
Conclusions:
- While surgery showed higher overall survival, overestimation of clinical stage complicates direct comparison.
- Factors like ureteral risk and lymph node involvement may contraindicate surgery in some stage IIb cases.
- Restraint in surgical treatment for stage IIb cervical cancer is suggested due to these findings.